Appeal No. 1997-2336
Application No. 08/256,065
There are no references relied upon by the examiner in this appeal.
The following references are relied upon by appellants:
Thun et al. (Thun I), "Aspirin Use and Reduced Risk of Fatal Colon Cancer," New England
Journal of Medicine, Vol. 325, pp. 1593-96 (1991)
Gridley et al. (Gridley), "Incidence of Cancer Among Patients With Rheumatoid Arthritis,”
Journal of the National Cancer Institute, Vol. 85, No. 4, pp. 307-311 (1993)
Thun et al., “Aspirin Use and Risk of Fatal Cancer,” Cancer Research, Vol. 53, pp. 1322-
1327 (1993)
Kelloff et al. (Kelloff I), “Chemopreventive Drug Development: Perspectives and Progress,”
Cancer Epidemiology, Biomarkers & Prevention, Vol. 3, pp. 85-98 (1994)
Kelloff et al. (Kelloff II), "Strategy and Planning for Chemopreventive Drug Development:
Clinical Development Plans,” Journal of Cellular Biochemistry, Supplement, Vol. 20, pp.
55-62 (1994)
Morgan et al. (Morgan), “NSAIDs and the Chemoprevention of Esophageal Cancer,” The
Lancet, Vol. 343, pp. 176-177 (1994)
Paganini-Hill, “Aspirin and the Prevention of Colorectal Cancer: A Review of the
Evidence,” Seminars in Surgical Oncology, Vol. 10, pp. 158-164 (1994)
Schreinemachers et al. (Schreinemachers), “Aspirin Use and Lung, Colon, and Breast
Cancer Incidence in a Prospective Study,” Epidemiology, Vol. 5, No. 2, pp. 138-146
(1994)
Baron et al. (Baron), “A Broad Anticancer Effect of Aspirin?”, Epidemiology, Vol. 5,
No. 2, pp. 133-135 ((March 1994)
Baron, “Aspirin and Cancer,” Preventive Medicine, Vol. 24, pp. 121-124 (1995)
Morgan, “NSAIDs and the Chemoprevention of Colon and Esophageal Cancer,” Gut, Vol.
36, pp. 153-154 (1995)
Stellman, “Aspirin and Cancer: Report on an American Health Foundation Workshop,”
Preventive Medicine, Vol. 24, pp. 101-102 (1995)
3
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007